GABA‐Benzodiazepine‐Barbiturate Receptor Interactions

Journal of Neurochemistry

Volumn 37, Issue 1, 1981, Pages 1-13

  Olsen, Richard W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; 4 PIPERIDINESULFONIC ACID; ARECAIDINE; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE RECEPTOR; BICUCULLINE; DRUG RECEPTOR; GABOXADOL; HOMOTAURINE; MUSCIMOL; PENTOBARBITAL; PICROTOXIN; PICROTOXININ;

CHLORIDE CHANNEL; DIAZEPAM H 3; DIHYDROPICROTOXININ H 3; PHARMACOKINETICS;

ANIMAL; BARBITURATES; BENZODIAZEPINES; BRAIN; GAMMA-AMINOBUTYRIC ACID; KINETICS; PICROTOXIN; RECEPTORS, CELL SURFACE; RECEPTORS, DRUG; RECEPTORS, GABA-A; RECEPTORS, NEUROTRANSMITTER; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0019459495     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.1981.tb05284.x     Document Type: Article

References (146)

1. GABA agonists and antagonists
2. Anion permeability of the synaptic and nonsynaptic motoneurone membrane
3. Solubilization of the benzodiazepine receptor from rat brain
4. Solubilization of γ‐aminobutyric acid receptor from rat brain
5. Identification of inosine and hypoxanthine as endogenous ligands for the brain benzodiazepine‐binding sites
6. Picrotoxin convulsions involve synaptic and nonsynaptic mechanisms on cultured mouse spinal neurons
7. Muscimol binding in rat brain: Association with synaptic GABA receptors
8. 3H‐diazepam binding by SQ65396: A novel anti‐anxiety agent
9. Changes in benzodiazepine receptors following GABAergic denervation of substantia nigra
10. Kainic acid differentiates GABA receptors from benzodiazepine receptors in the rat cerebellum
11. Reversal ofthe action of amino acid antagonists by barbiturates and other hypnotic drugs
12. Bicyclic phosphorus esters that are potent convulsants and GABA antagonists
13. Ontogenetic development of benzodiazepine receptors in the rat brain
14. Partial agonists for brain GABA/benzodiazepine receptor complex
15. Urinary and brain β‐carboline‐3‐carboxylates as potent inhibitors of brain benzodiazepine receptors
16. 3H‐diazepam to the benzodiazepine receptor
17. 3H]diazepam binding at the benzodiazepine‐GABA receptor‐ionophore complex
18. The delay in onset of action of intravenously injected anaesthetics
19. Solubilization of γ‐aminobutyric acid (GABA) and benzodiazepine (BZ) binding‐sites by detergents
20. GABA receptor binding in rat striatum: Localization and effects of denervation
21. The postnatal development of the benzodiazepine receptor in the cerebral cortex and cerebellum of the rat
22. Neurotransmitter receptor localizations: Brain lesion induced alterations in benzodiazepine, GABA. beta‐adrenergic and histamine HI‐receptor binding
23. 3H‐diazepam binding in rat cortex. Eur
24. Studies of digitoninsolubilized benzodiazepine receptor system
25. Solubilization and partial purification of the GABA receptor from mouse brain and a binding assay for the solubilized receptor
26. Molecular mechanisms in the receptor action of benzodiazepines
27. Is the benzodiazepine receptor coupled to a chloride anion channel
28. Neurochemical aspects of the ontogenesis of GABAnergic neurons in the rat brain
29. Is the benzodiazepine receptor purinergic
30. 3H]diazepam binding in rat brain by dipyridamole and by 1‐methylisoguanosine, a marine natural product with muscle relaxant activity
31. Identification of an endogenous peptide‐ligand for the benzodiazepine receptor
32. Modulation of benzodiazepine binding sites in calf cortex by an endogenous factor and GABAergic ligands
33. Properties of γ‐aminobutyric acid (GABA) receptor binding in rat brain synaptic membrane fractions
34. Influences of ions, enzyme, and detergents on γ‐aminobutyric acid‐receptor binding in synaptic membranes of rat brain
35. Alterations of brain neurotransmitter receptor binding in HuntingtoN's chorea
36. Purification of the solubilized benzodiazepine receptor
37. Effect of GABAergic drugs on benzodiazepine binding site sensitivity in rat cerebral cortex
38. Soluble benzodiazepine receptors: GABAergic regulation
39. Benzodiazepine recognition sites on GABA receptors
40. Properties of soluble and partially purified benzodiazepine and γ‐aminobutyric acid (GABA) receptors
41. Solubilization of histamine H‐1. GABA and benzodiazepine receptors
42. Solubilization of gamma‐aminobutyric acid receptor protein from mammalian brain
43. Endogenous inhibitor of GABA binding in mammalian brain
44. Gamma‐aminobutyric acid binding in mammalian brain: Receptor‐like specificity of sodium‐independent sites
45. An endogenous protein modulates the affinity of GABA and benzodiazepine receptors in rat brain
46. Biochemical evidence for two classes of GABA receptors in rat brain
47. GABA‐modulin regulates solubilized benzodiazepine and GABA recognition sites
48. Facilitation of GABA‐ergic Transmission by drugs
49. Pentobarbital: Stereo‐specific actions of the (+) and (‐) isomers revealed on cultured mammalian neurons
50. GABA receptors and phospholipids
51. Barbiturates and GABA receptors
52. THIP and isoguvacine are partial agonists of GABA‐stimulated benzodiazepine receptor binding
53. Stimulation of benzodiazepine receptor binding by gamma‐aminobutyric acid
54. Is stimulation of benzodiazepine receptor binding mediated by a novel GABA receptor
55. 3H‐flunitrazepam binding to the GABA/benzodiazepine receptor complex of rat cerebellum
56. Dihydromuscimol, thiomuscimol and related heterocyclic compounds as GABA analogues
57. Putative benzodiazepine receptor: A protein solubilised from brain
58. Picrotoxinin binding as a probe of the GABA postsynaptic membrane receptor‐ionophore complex
59. Barbiturate receptors are coupled to benzodiazepine receptors
60. Some anticonvulsants interact with the GABA receptor‐ionophore at barbiturate/picrotoxin receptor sites
61. Differential solublization of γ‐aminobutyric acid receptive sites from membranes of mammalian brain
62. Evidence that benzodiazepine receptors reside on cerebellar Purkinje cells: Studies with “nervous” mutant mice
63. 3H]GABA binding in brains from HuntingtoN's chorea patients: Altered regulation by phospholipids
64. 3H] GABA) binding in the human brain: Alterations in ParkinsoN's disease
65. 3H‐GABA binding in HuntingtoN's chorea
66. Enhancement of GABA‐mediated postsynaptic inhibition in cultured mammalian spinal cord neurons: A common mode of anticonvulsant action
67. 3H‐diazepam to rat brain
68. Ontogenetic changes in GABA modulation of brain benzodiazepine binding
69. Purinergic inhibition of diazepam binding to rat brain (in vitro)
70. Facilitation of benzodiazepine binding by sodium chloride and GABA
71. Facilitation of specific benzodiazepine binding in rat brain membrane fragments by a number of anions
72. Endogenous regulators of benzodiazepine recognition sites
73. The GABA agonist THIP, a muscimol analogue, does not interfere with the benzodiazepine binding site on rats cortical membranes
74. Assaying GABA‐modulin activity in brain extracts: Resolution of inherent difficulties
75. GABA‐induced conductance fluctuations in cultured spinal neurones
76. 3H] GABA binding by the novel anxiolytic ICI 136,753 and benzodiazepines
77. Benzodiazepine receptors: Demonstration in the central nervous system
78. 3H]bicuculline methiodide in rat cerebellum
79. Nicotinamide is a brain constituent with benzodiazepine‐like actions
80. Benzodiazepine receptor protein identified and visualized in brain tissue by a photoaffinity label
81. 3H‐isoguvacine to mouse brain synaptic membranes
82. GABA binding in mammalian brain: Inhibition by endogenous GABA
83. Prolongation of hippocampal inhibitory post‐synaptic potentials by barbiturates
84. Electrophysiological studies of the mode of action of GABA on vertebrate central neurons
85. The inhibition of GABA‐stimulated benzodiazepine binding by a convulsant benzodiazepine
86. Biochemistry of GABA receptor proteins in mammalian brain
87. Endogenous inhibitors of picrotoxinin‐convulsant binding sites in rat brain
88. Convulsant and anticonvulsant drug binding sites related to GABA‐related chloride ion channels
89. Convulsant and anticonvulsant drug binding sites related to the GABA receptor/ionophore system
90. Localization of gamma‐aminobutyric acid receptor binding in the mammalian cerebellum: High levels in granule layer and depletion in granular cerebella of mutant mice
91. Effects of drugs on γ‐aminobutyric acid receptors, uptake, release and synthesis in vitro
92. Dihydropicrotoxinin binding to crayfish muscle sites possibly related to γ‐aminobutyric acid receptor‐ionophores
93. GABA receptor and ionophore binding sites: Interactions with various drugs
94. GABA receptor binding and endogenous inhibitors in normal human brain and HuntingtoN's disease
95. Neurotransmitter receptors–Biochemistry and alterations in neuropsychiatric disorders
96. γ‐ Aminobutyric acid receptor binding in mammalian brain: Heterogeneity of binding sites
97. Barbiturates enhance GABA receptor binding in mammalian brain membranes in vitro
98. Ontogeny of GABA and benzodiazepine receptors: Effects of Triton X‐100, bromide and muscimol
99. Autoradiographic localization of γ‐aminobutyric acid (GABA) receptors in the rat cerebellum
100. 3H]‐diazepam binding from bovine cerebral cortex
101. +‐independent GABA and benzodiazepine binding sites in rat CNS
102. In vitro modulation by SQ 20009 and SQ 65396 of GABA receptor binding in rat CNS membranes
103. The benzodiazepine receptor: Its development and its modulation by γ‐aminobutyric acid
104. GABA receptor binding in the Parkinsonian brain
105. Enhancement of benzodiazepine binding by the novel anxiolytic ICI 136,753
106. Reduction of gamma‐aminobutyric acid (GABA)‐mediated transmission by a convulsant benzodiazepine
107. Solubilization and properties of a benzodiazepine receptor from calf cortex
108. Supersensitivity to GABA's effect on benzodiazepine receptors develops after striatonigral lesions
109. Molecular heterogeneity of benzodiazepine receptors
110. Gamma‐aminobutyric acid (GABA) receptor binding selectively depleted by viral induced granule cell loss in hamster cerebellum
111. Reduction in benzodiazepine receptors associated with Purkinje cell degeneration in “nervous” mutant mice
112. Increased benzodiazepine receptor number elicited in vitro by a novel purine, EMD 28422
113. 3H] diazepam binding to benzodiazepine receptors
114. Reduction of number of benzodiazepine binding sites in the caudate nucleus of the rat after kainic acid injections
115. Neuronal localization of benzodiazepine receptors in the murine cerebellum
116. GABA receptors regulate the affinities of anions required for brain specific benzodiazepine binding
117. Benzodiazepine receptors in rat brain
118. Some properties of brain specific benzodiazepine receptor: New evidence for multiple receptors
119. Stimulation of benzodiazepine receptor binding by SQ 20009 is chloride‐dependent and picrotoxin‐sensitive
120. Interaction of SQ 20009 and GABA‐like drugs its modulators of benzodiazepine receptor binding
121. Heterogeneity of benzodiazepine receptors in rat cerebellum and hippocampus
122. 3H] flunitrazepam binding by the muscimol analogues THIP and piperidine‐4‐sulfonic acid
123. 3H) flunitrazepam binding to the GABA/benzodiazepine receptor complex of the cerebellum
124. GABAergic modulation of benzodiazepine binding site sensitivity
125. Receptors for the age of anxiety: Pharmacology of the benzodiazepines
126. Is the picrotoxinin binding site at the GABA synapse a site of action for barbiturates
127. 3H] γ‐aminobutyric acid receptor binding to rat brain membranes
128. Interaction of barbiturates with dihydropicrotoxinin binding sites related to the GABA receptor‐ionophore system
129. Cage convulsants inhibit picrotoxinin binding
130. Picrotoxinin binding sites at the GABA synapse: A target for drug action
131. 3H] α‐dihydropicrotoxinin, a gamma‐aminobutyric acid synaptic antagonist, to rat brain membranes
132. Dihydropicrotoxinin binding sites in rat brain: Comparison to GABA receptors
133. Purification of an endogenous protein inhibitor of the high affinity binding of γ‐aminobutyric acid to synaptic membranes of rat brain
134. Characterisation of denervation supersensitivity in the striatonigral GABA pathway of the kainic acid‐lesioned rat and in HuntingtoN's disease
135. 3H‐muscimol binding to mouse brain membranes
136. 3H‐flunitrazepam binding in the rat brain
137. 3H‐diazepam to rat brain membranes in vitro by SQ 20009, a novel anxiolytic, gamma‐aminobutyric acid (GABA) and muscimol
138. 1a
139. Heterogeneity of benzodiazepine receptors in the central nervous system demonstrated with kenazepine, an alkylating benzodiazepine
140. Autoradiographic localisation of benzodiazepine receptors in the brains of humans and animals
141. Solubilization of benzodiazepine binding site from rat cortex
142. Gamma‐aminobutyric acid binding to receptors sites in the rat central nervous system